Patient-derived Xenografts of Hematological Malignancies: Model Systems for Drug Development and Tumor Biology Research

In recent years, there have been multiple efforts in the establishment and characterization of large collections of Patient-Derived Tumor Xenograft (PDX) models for cancer research.

14 April 2016 from 11am to 12pm

Currently in read only mode, sorry about that, please try again in a few hours.

Tell your friends!

Share this event with your friends on Twitter


See something wrong?

Report an issue with this event